Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels

被引:2
作者
Pardo, Jessica [1 ,2 ]
Capdevila-Lacasa, Clara [1 ,2 ]
Segura, Barbara [1 ,2 ,3 ]
Pane, Adriana [4 ,5 ]
Montserrat, Cristina [5 ]
Forga-Visa, Maria de Tallo [5 ]
Moreno, Pedro J. [6 ,7 ,8 ,9 ]
Garrabou, Gloria [6 ,7 ,8 ,9 ]
Grau-Junyent, Josep M. [6 ,7 ,8 ,9 ]
Junque, Carme [1 ,2 ,3 ]
机构
[1] Univ Barcelona, Inst Neurosci, Dept Med, Med Psychol Unit, C Casanova 143, Barcelona 08036, Catalonia, Spain
[2] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Fundacio Recerca Clin Barcelona FRCB, Barcelona, Catalonia, Spain
[3] Biomed Res Networking Ctr Neurodegenerat Dis, CIBERNED, ISCIII, CB06 05 0018, Barcelona, Catalonia, Spain
[4] Biomed Res Networking Ctr Physiopathol Obes & Nutr, Barcelona, Catalonia, Spain
[5] Hosp Clin Barcelona, Endocrinol & Nutr Dept, Adult Inherited Metab Disorders Unit UECMA, Barcelona, Catalonia, Spain
[6] Hosp Clin Barcelona, Adult Inherited Metab Disorders Unit UECMA, Internal Med Dept, Barcelona, Catalonia, Spain
[7] Univ Barcelona, Inherited Metab Dis & Muscle Disorders Res, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Recerca Biomed Cellex, Barcelona, Catalonia, Spain
[8] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Catalonia, Spain
[9] Biomed Res Networking Ctr Rare Dis CIBERER, Barcelona, Catalonia, Spain
关键词
Phenylketonuria; Adult early-treated patients; Blood phenylalanine levels; Neuroimaging; Volumetry; Neuropsychological assessment; WHITE-MATTER INTEGRITY; INDIVIDUALS; CHILDREN; ABNORMALITIES; AGE; PKU;
D O I
10.1186/s11689-024-09553-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Continued dietary treatment since early diagnosis through newborn screening programs usually prevents brain-related complications in phenylketonuria (PKU). However, subtle neurocognitive and brain alterations may be observed in some adult patients despite early treatment. Nevertheless, neuropsychological and neuroimaging studies in the field remain scarce. Objectives This work aimed to determine possible neuropsychological and structural brain alterations in treated adult patients with PKU. Methods Thirty-five patients with PKU and 22 healthy controls (HC) underwent neuropsychological assessment and T1-weighted magnetic resonance imaging on a 3 T scanner. FreeSurfer (v.7.1) was used to obtain volumetric measures and SPSS (v27.0.1.0) was used to analyze sociodemographic, neuropsychological, volumetric, and clinical data (p < 0.05). Results Adult patients with PKU showed significantly lower performance than HC in Full Scale IQ (t = 2.67; p = .010) from the WAIS-IV. The PKU group also showed significantly lower volumes than HC in the pallidum (U = 224.000; p = .008), hippocampus (U = 243.000; p = .020), amygdala (U = 200.000; p = .002), and brainstem (t = 3.17; p = .006) as well as in total cerebral white matter volume (U = 175.000; p = .001). Blood phenylalanine (Phe) levels in PKU patients were negatively correlated with the pallidum (r = -0.417; p = .013) and brainstem (r = -0.455, p = .006) volumes. Conclusions Adult patients with early-treated PKU showed significantly lower global intelligence than HC. Moreover, these patients showed reduced global white matter volume as well as reductions in the volume of several subcortical grey matter structures, which might be related to the existence of underlying neurodevelopmental alterations. Higher blood Phe levels were also negatively correlated with pallidum and brainstem, suggesting a higher vulnerability of these structures to Phe toxicity.
引用
收藏
页数:10
相关论文
共 41 条
[21]   White matter microstructural damage in early treated phenylketonuric patients [J].
Julieta Gonzalez, Maria ;
Rebollo Polo, Monica ;
Ripolles, Pablo ;
Gassio, Rosa ;
Ormazabal, Aida ;
Sierra, Cristina ;
Colome Roura, Roser ;
Artuch, Rafael ;
Campistol, Jaume .
ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
[22]   NEUROPATHOLOGY OF PHENYLKETONURIA [J].
MALAMUD, N .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1966, 25 (02) :254-&
[23]   The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study [J].
Mastrangelo, Mario ;
Chiarotti, Flavia ;
Berillo, Luana ;
Caputi, Caterina ;
Carducci, Claudia ;
Di Biasi, Claudio ;
Manti, Filippo ;
Nardecchia, Francesca ;
Leuzzi, Vincenzo .
MOLECULAR GENETICS AND METABOLISM, 2015, 116 (03) :171-177
[24]   Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria [J].
Moat, Stuart J. ;
Schulenburg-Brand, Danja ;
Lemonde, Hugh ;
Bonham, James R. ;
Weykamp, Cas W. ;
Mei, Joanne V. ;
Shortland, Graham S. ;
Carling, Rachel S. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (02) :179-188
[25]   Compromised white matter is related to lower cognitive performance in adults with phenylketonuria [J].
Muri, Raphaela ;
Maissen-Abgottspon, Stephanie ;
Reed, Murray Bruce ;
Kreis, Roland ;
Hoefemann, Maike ;
Radojewski, Piotr ;
Pospieszny, Katarzyna ;
Hochuli, Michel ;
Wiest, Roland ;
Lanzenberger, Rupert ;
Trepp, Roman ;
Everts, Regula .
BRAIN COMMUNICATIONS, 2023, 5 (03)
[26]   Cortical thickness and its relationship to cognitive performance and metabolic control in adults with phenylketonuria [J].
Muri, Raphaela ;
Maissen-Abgottspon, Stephanie ;
Rummel, Christian ;
Rebsamen, Michael ;
Wiest, Roland ;
Hochuli, Michel ;
Jansma, Bernadette M. ;
Trepp, Roman ;
Everts, Regula .
JOURNAL OF INHERITED METABOLIC DISEASE, 2022, 45 (06) :1082-1093
[27]   Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study [J].
Nardecchia, Francesca ;
Manti, Filippo ;
Chiarotti, Flavia ;
Carducci, Claudia ;
Carducci, Carla ;
Leuzzi, Vincenzo .
MOLECULAR GENETICS AND METABOLISM, 2015, 115 (2-3) :84-90
[28]   Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria [J].
Peng, Huiling ;
Peck, Dawn ;
White, Desiree A. ;
Christ, Shawn E. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (02) :237-243
[29]   Global and regional volume changes in the brains of patients with phenylketonuria [J].
Pérez-Dueñas, B ;
Pujol, J ;
Soriano-Mas, C ;
Ortiz, H ;
Artuch, R ;
Vilaseca, MA ;
Campistol, J .
NEUROLOGY, 2006, 66 (07) :1074-1078
[30]  
Pfaendner NH, 2005, AM J NEURORADIOL, V26, P1681